|
SFPQ expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.004120E-03 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
6.817000E-03 |
| Normal-vs-Stage2 |
4.47330000000745E-05 |
| Normal-vs-Stage3 |
6.240300E-04 |
| Normal-vs-Stage4 |
4.15679999999918E-05 |
| Stage1-vs-Stage2 |
7.081400E-03 |
| Stage1-vs-Stage3 |
9.717700E-02 |
| Stage1-vs-Stage4 |
1.741360E-03 |
| Stage2-vs-Stage3 |
1.268450E-01 |
| Stage2-vs-Stage4 |
7.542200E-01 |
| Stage3-vs-Stage4 |
1.891600E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.704080E-03 |
| Normal-vs-AfricanAmerican |
3.573800E-02 |
| Normal-vs-Asian |
2.829900E-02 |
| Caucasian-vs-AfricanAmerican |
5.478800E-01 |
| Caucasian-vs-Asian |
2.810400E-01 |
| AfricanAmerican-vs-Asian |
8.403600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
9.442200E-04 |
| Normal-vs-Female |
1.337470E-03 |
| Male-vs-Female |
6.242000E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.865750E-02 |
| Normal-vs-Age(41-60Yrs) |
3.965700E-04 |
| Normal-vs-Age(61-80Yrs) |
2.1932999999974E-05 |
| Normal-vs-Age(81-100Yrs) |
1.492770E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
7.439900E-03 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
9.61080000000392E-05 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.020200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
9.663500E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
8.422000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.017400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
9.268300E-02 |
| Classical-VS-Follicular |
4.45920000000655E-05 |
| Classical-VS-Other |
4.427000E-01 |
| Classical-VS-Normal |
1.185520E-02 |
| Tall-VS-Follicular |
1.252380E-01 |
| Tall-VS-Other |
9.270200E-01 |
| Tall-VS-Normal |
9.383000E-04 |
| Follicular-VS-Other |
4.784200E-01 |
| Follicular-VS-Normal |
1.61466999999416E-05 |
| Other-VS-Normal |
1.485230E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.029600E-04 |
| Normal-vs-N1 |
5.130500E-02 |
| N0-vs-N1 |
1.875870E-02 |
|
|
